Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × tazemetostat × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Follicular 10 Sarcoma 5 Lymphoma, Non-Hodgkin 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, B-Cell 4 Prostatic Neoplasms 3 Sarcoma, Synovial 2 Rhabdoid Tumor 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell 2 Lymphoma 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Tertiary Lymphoid Structures 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Nerve Sheath Neoplasms 1 Multiple Myeloma 1 Mesothelioma 1 Melanoma 1

Interventions

Rituximab 41 Cyclophosphamide 31 Lenalidomide 24 fludarabine 19 zanubrutinib 12 venetoclax 11 obinutuzumab 11 fludarabine phosphate 9 Bendamustine Hydrochloride 9 orelabrutinib 8 ibrutinib 8 Vincristine 8 Magnetic Resonance Spectroscopy 8 pirtobrutinib 7 Whole-Body Irradiation 7 Prednisone 7 Specimen Handling 6 Doxorubicin 6 CT-P10 6 Mycophenolic Acid 5 Etoposide 5 Biopsy 5 pembrolizumab 4 Nivolumab 4 Melphalan 4 tafasitamab 3 Sirolimus 3 Cyclosporine 3 parsaclisib 2 copanlisib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡